INSTITUTE FOR PROTEIN INNOVATION I… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2016

Legal Domicile

Principal Officer

KENNETH FASMAN PHD

Phone

6173147970

Tax Period

2024-07-01 to 2025-06-30

INSTITUTE FOR PROTEIN INNOVATION INC, founded in 2016, is a community nonprofit in the Medical Research sector that reported $7.5M in total revenue in fiscal year 2024. Revenue surged 61% from the prior year, signaling strong growth momentum. Expenses of $17.5M exceeded revenue, resulting in a 134% operating deficit.

Mission

THE INSTITUTE FOR PROTEIN INNOVATION IS ADVANCING PROTEIN SCIENCE TO ACCELERATE RESEARCH AND IMPROVE HUMAN HEALTH.

Program Service Accomplishments

Program 1

Expenses: $12,971,110 Revenue: $97,790

THE INSTITUTE PROVIDES ACADEMIA AND INDUSTRY WITH SYNTHETIC ANTIBODIES AND DEEP PROTEIN EXPERTISE IN CONJUNCTION WITH BOSTON CHILDREN'S HOSPITAL AND OTHER ACADEMIC AND INDUSTRY PARTNERS. SINCE...

THE INSTITUTE PROVIDES ACADEMIA AND INDUSTRY WITH SYNTHETIC ANTIBODIES AND DEEP PROTEIN EXPERTISE IN CONJUNCTION WITH BOSTON CHILDREN'S HOSPITAL AND OTHER ACADEMIC AND INDUSTRY PARTNERS. SINCE INCEPTION, THE INSTITUTE HAS PRODUCED AND CHARACTERIZED THOUSANDS OF SYNTHETIC RECOMBINANT ANTIBODIES AGAINST HUNDREDS OF PROTEIN TARGETS VIA ITS HIGH-THROUGHPUT ANTIBODY DISCOVERY PLATFORM. THE INSTITUTE IS COLLABORATING WITH RESEARCHERS IN INDUSTRY AND ACADEMIA TO USE THESE ANTIBODIES TO ACCELERATE RESEARCH AND ENABLE RESEARCH ON NEW THERAPEUTICS THAT IMPROVE HUMAN HEALTH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $500,000

Program Service Revenue $97,790

Investment Income $6,883,739

Other Revenue $0

TOTAL REVENUE $7,481,529

Expense Breakdown

Grants Paid $0

Salaries & Benefits $8,553,501

Fundraising Expenses $0

Program Expenses $12,971,110

Other Expenses $8,983,702

TOTAL EXPENSES $17,537,203

Year-over-Year Comparison

	2024	2023	Change
Revenue	$7,481,529	$4,647,929	+0.6%
Expenses	$17,537,203	$14,602,368	+0.2%
Net Income	$-10,055,674	$-9,954,439	+0.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,103,247

Total Directors

$809,046

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
KENNETH FASMAN	PRESIDENT & CEO/EX-OFFICIO	40.00	Officer Director	$698,168	$110,878	$809,046
SAMANTHA SINGER	CHAIR	1.00	Officer Director	$0	$0	$0
MICHAEL O'HARA	TREASURER	1.00	Officer Director	$0	$0	$0
DR TIMOTHY A SPRINGER	CO-FOUNDER/DIRECTOR	1.00	Director	$0	$0	$0
DR STEVEN C ALMO	DIRECTOR	1.00	Director	$0	$0	$0
DR MAYKIN HO	DIRECTOR	1.00	Director	$0	$0	$0
DR AMIR NASHAT	DIRECTOR	1.00	Director	$0	$0	$0
DR STEPHEN BLACKLOW	DIRECTOR	1.00	Director	$0	$0	$0
ISRAEL ROZEN	DIRECTOR	1.00	Director	$0	$0	$0
DR AURO NAIR	DIRECTOR	1.00	Director	$0	$0	$0
DR RUSTY WILLIAMS	DIRECTOR	1.00	Director	$0	$0	$0
DR JEFFREY FLIER	DIRECTOR (UNTIL 12/24)	1.00	Director	$0	$0	$0
BETTINA STEVENS	CFO (UNTIL 10/24)	40.00	Officer	$248,242	$45,959	$294,201
ROB MEIJERS	SENIOR DIRECTOR ANTIBODY PLATFORM	40.00	Highest	$278,006	$52,322	$330,328
TRISHA GURA	DIR. OF COMMUNICATIONS	40.00	Highest	$239,660	$44,295	$283,955
ANDRE TEIXEIRA	SR. DIR. OF ANTIBODY PLATFORM	40.00	Highest	$238,270	$45,072	$283,342
DEBORAH MOSHINSKY	DIRECTOR ANTIBODY CHARACTERIZATION	40.00	Highest	$237,606	$42,777	$280,383
CURTIS WALTON	DIRECTOR OF LABORATORY AUTOMATION	40.00	Highest	$233,334	$44,154	$277,488

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$7,481,529	$17,537,203	$204,496,998	$-10,055,674
2024	$4,647,929	$14,602,368	$201,899,474	$-9,954,439
2023	$4,022,792	$13,197,650	$196,826,153	$-9,174,858
2022	$5,178,433	$10,986,031	$191,011,980	$-5,807,598
2021	$200,786,087	$9,301,960	$219,080,402	$191,484,127
2020	$24,674,930	$7,577,015	$26,558,611	$17,097,915
2019	$1,521,195	$7,094,240	$9,234,111	$-5,573,045
2018	$8,755,283	$3,855,437	$15,361,567	$4,899,846

INSTITUTE FOR PROTEIN INNOVATION INC